Related Experiment Videos
Captopril in severe childhood hypertension--reversible anaemia with high dosage
Insights
Captopril effectively manages severe hypertension in children, particularly those with haemolytic uraemic syndrome. Dose adjustment is key to mitigating side effects like anemia while maintaining blood pressure control.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Pharmacology
Background:
- Limited data exists on chronic angiotensin-converting enzyme (ACE) inhibition in pediatric patients.
- Captopril use in children has generally shown minimal side effects in prior reports.
Observation:
- A 7-year-old boy with severe hypertension secondary to hemolytic uremic syndrome was treated with captopril.
- Initial high-dose captopril achieved good blood pressure control but led to pronounced anemia within 3 months.
Findings:
- Dose reduction of captopril resolved the anemia while sustaining adequate hypertension management.
- Serial echocardiographic studies demonstrated favorable hemodynamic effects of captopril in pediatric antihypertensive therapy.
Implications:
- This case highlights the potential for captopril in treating severe pediatric hypertension, especially in hemolytic uremic syndrome.
- Careful dosage titration is recommended to balance efficacy and minimize adverse effects like anemia in children.
- Echocardiography is valuable for monitoring hemodynamic responses to captopril in pediatric patients.
Abstract:
Experience with chronic inhibition of the angiotensin-converting enzyme in children is limited to cases refractory to all other forms of treatment. In reports dealing with the use of captopril (Capoten-R) in children no important side-effects are mentioned. This report describes a 7-year-old boy with severe hypertension secondary to haemolytic uraemic syndrome. Good pressure control was obtained after introduction of captopril. However, under the high initial dosage, pronounced anaemia developed within the first 3 months of treatment. The anaemia responded to dose-reduction while pressure control was maintained. Serial echocardiographic studies were performed. They illustrate the beneficial haemodynamic effects of captopril in the follow-up of children under antihypertensive treatment. Some recommendations are made on the use of captopril in children.